Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus
Tóm tắt
In addition to disturbed apoptosis and insufficient clearance of apoptotic cells, there is recent evidence for a role of neutrophils in the aetiopathogenesis of systemic lupus erythematosus (SLE). In response to various stimuli, neutrophils can rapidly release DNA fibres decorated with citrullinated histones and anti-microbial peptides. These structures are referred to as neutrophil extracellular traps (NETs). In addition to apoptotic cell-derived microparticles, these NETs may comprise a further source of autoantigens, able to drive the autoimmune response in SLE. Our group recently identified specific histone modifications occurring during apoptosis that play an important role in the autoimmune response in SLE. In the current study, we evaluated the presence and immunostimulatory potential of these previously identified histone modifications in NETs. Compared to NETs from healthy donors, the histones present in NETs formed by SLE-derived neutrophils contain increased amounts of acetylated and methylated residues, which we previously observed to be associated with apoptosis and SLE. Treatment of neutrophils with histone deacetylase (HDAC) inhibitor Trichostatin A (TSA), prior to induction of NETosis, induced NETs containing hyperacetylated histones, endowed with an increased capacity to activate macrophages. This implies that specific histone modifications, in particular acetylation, might enhance the immunostimulatory potential of NETs in SLE.
Từ khóa
Tài liệu tham khảo
Munoz, 2008, Apoptosis in the pathogenesis of systemic lupus erythematosus, Lupus, 17, 371, 10.1177/0961203308089990
Jin, 2005, Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus, Clin Rheumatol, 24, 107, 10.1007/s10067-004-0972-x
Ren, 2003, Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus, Arthritis Rheum, 48, 2888, 10.1002/art.11237
Kaplan, 2002, The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells, J Immunol, 169, 6020, 10.4049/jimmunol.169.10.6020
Shoshan, 2001, Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells, J Immunol, 167, 5963, 10.4049/jimmunol.167.10.5963
Gaipl, 2006, Clearance of apoptotic cells in human SLE, Curr Dir Autoimmun, 9, 173
Herrmann, 1998, Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus, Arthritis Rheum, 41, 1241, 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H
Licht, 2004, Decreased phagocytosis of apoptotic cells in diseased SLE mice, J Autoimmun, 22, 139, 10.1016/j.jaut.2003.11.003
Muñoz, 2010, The role of defective clearance of apoptotic cells in systemic autoimmunity, Nat Rev Rheumatol, 6, 280, 10.1038/nrrheum.2010.46
van der Vlag, 2011, Lupus nephritis: role of antinucleosome autoantibodies, Semin Nephrol, 31, 376, 10.1016/j.semnephrol.2011.06.009
Pradhan, 2004, Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies, J Assoc Physicians India, 52, 533
Brinkmann, 2004, Neutrophil extracellular traps kill bacteria, Science, 303, 1532, 10.1126/science.1092385
Cheng, 2013, NET balancing: a problem in inflammatory lung diseases, Front Immunol, 4, 1, 10.3389/fimmu.2013.00001
Cools-Lartigue, 2013, Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis, J Clin Invest, 123, 3446, 10.1172/JCI67484
Fuchs, 2010, Extracellular DNA traps promote thrombosis, Proc Natl Acad Sci USA, 107, 15880, 10.1073/pnas.1005743107
Yu, 2013, Neutrophil extracellular traps and systemic lupus erythematosus, J Clin Cell Immunol, 4, pii: 139, 10.4172/2155-9899.1000139
van der Heijden, 2005, Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote, Mech Dev, 122, 1008, 10.1016/j.mod.2005.04.009
Dieker, 2007, Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus, Arthritis Rheum, 56, 1921, 10.1002/art.22646
van Bavel, 2009, Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies, Mol Immunol, 47, 511, 10.1016/j.molimm.2009.08.009
van Bavel, 2011, Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus, Ann Rheum Dis, 70, 201, 10.1136/ard.2010.129320
Murao, 1983, Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate, Cancer Res, 43, 4989
Garcia-Romo, 2011, Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus, Sci Transl Med, 3, 73ra20, 10.1126/scitranslmed.3001201
Denny, 2010, A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs, J Immunol, 184, 3284, 10.4049/jimmunol.0902199
Skiljevic, 2013, Serum DNase I activity in systemic lupus erythematosus: correlation with immuno serological markers, the disease activity and organ involvement, Clin Chem Lab Med, 51, 1083, 10.1515/cclm-2012-0521
Leffler, 2012, Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease, J Immunol, 188, 3522, 10.4049/jimmunol.1102404
Garcia, 2005, Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition, J Proteome Res, 4, 2032, 10.1021/pr050188r
Hu, 2008, Abnormal histone modification patterns in lupus CD4+ T cells, J Rheumatol, 35, 804
Liu, 2012, Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies, Arthritis Res Ther, 14, R25, 10.1186/ar3707